rs1317030435
Positions:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004415.4(DSP):c.3200C>T(p.Ala1067Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000124 in 1,613,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
DSP
NM_004415.4 missense
NM_004415.4 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 4.86
Genes affected
DSP (HGNC:3052): (desmoplakin) This gene encodes a protein that anchors intermediate filaments to desmosomal plaques and forms an obligate component of functional desmosomes. Mutations in this gene are the cause of several cardiomyopathies and keratodermas, including skin fragility-woolly hair syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06132555).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.3200C>T | p.Ala1067Val | missense_variant | 23/24 | ENST00000379802.8 | NP_004406.2 | |
DSP | NM_001319034.2 | c.3200C>T | p.Ala1067Val | missense_variant | 23/24 | NP_001305963.1 | ||
DSP | NM_001008844.3 | c.3200C>T | p.Ala1067Val | missense_variant | 23/24 | NP_001008844.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.3200C>T | p.Ala1067Val | missense_variant | 23/24 | 1 | NM_004415.4 | ENSP00000369129 | P2 | |
DSP | ENST00000418664.2 | c.3200C>T | p.Ala1067Val | missense_variant | 23/24 | 1 | ENSP00000396591 | A2 | ||
DSP | ENST00000710359.1 | c.3200C>T | p.Ala1067Val | missense_variant | 23/24 | ENSP00000518230 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152120
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461862Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727228
GnomAD4 exome
AF:
AC:
1
AN:
1461862
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
727228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74284
GnomAD4 genome
AF:
AC:
1
AN:
152120
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74284
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 19, 2017 | The p.Ala1067Val variant in DSP has not been previously reported in individuals with cardiomyopathy or in large population studies. Computational prediction too ls and conservation analysis suggest that the p.Ala1067Val variant may not impac t the protein, though this information is not predictive enough to rule out path ogenicity. While this variant is located within an exon, computational tools sug gest the creation of a novel splice site; however, this information is not predi ctive enough to determine pathogenicity. In summary, the clinical significance o f the p.Ala1067Val variant is uncertain. - |
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | provider interpretation | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Jun 02, 2017 | p.Ala1067Val (c.3200C>T) in exon 23 the DSP gene (NM_004415.2; 6:7579623C>T; GRCh37) Given the absent case data on this variant and that rare, missense variation is common in the general population, we consider this variant a variant of uncertain significance and we do not feel it is suitable for assessing risk in healthy relatives ("predictive genetic testing"). Missense variation in DSP must be interpreted with caution. This variant is novel. This variant has not been reported in individuals with cardiomyopathy. Another variant at this position (p.Ala1067Ser) has been reported in ClinVar in one individual with familial hypertrophy cardiomyopathy and is classified as a variant of uncertain significance. Multiple studies have found that rare, missense variation in DSP is common in the general population: According to the ExAC database's constraint data, DSP appears to be fairly tolerant to missense variation (Z=0.91), but not to loss of function/truncating variation (pLI - 1.000). This is supported by literature. In a study examining the genetic underpinnings of ARVC, 16% of 427 controls were found to have missense variants (Kapplinger et al., 2011). Kapplinger and colleagues also proposed that there is a "hot spot" of missense variation in DSP that causes ARVC - from amino acids 250-604. In another study that compared the genetic variation between pooled patients with cardiomyopathy and individuals in the general population via the ExAC database (60,000 control individuals), missense variation in DSP was NOT significantly enriched in cases of DCM or ARVC (Walsh et al., 2016). Another study (Amr et al., 2016) examined the prevalence of genetic variation in cardiomyopathy cases versus controls and determined that missense variation in DSP in general confers a minimal increase in disease risk (OR=0.62). This is in contrast to the high increase in disease risk loss-of-function variation in DSP confers (OR=18.21). Per the test report, "computational prediction tools and conservation analysis suggest that the p.Ala1067Val variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity." The alanine at codon 1067 is not completely conserved across species: elephants, chickens, and other lower vertebrates have other amino acids present at this location. Neighboring amino acids are not completely conserved across species. A nearby variant is reported as pathogenic; however, this is a truncating variant (p.Tyr1065Ter). Loss-of-function variants are a known mechanism of disease in DSP. Furthermore, according to the test report, this variant may introduce a novel splice site: "while this variant is located within an exon, computational tools suggest the creation of a novel splice site; however, this information is not predictive enough to determine pathogenicity." This variant is not present in the Genome Aggregation Consortium Dataset (gnomAD; http://gnomad.broadinstitute.org/), which currently includes variant calls on >140,000 unrelated individuals of African, Asian, European, Latino, and Ashkenazi descent. The average coverage at that site in gnomAD is 87x in exomes and 34x in genomes. Another variant at this codon, p.Ala1067Ser is present in 1 out of 11,149 individuals of European descent. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MutPred
Gain of methylation at K1064 (P = 0.1057);Gain of methylation at K1064 (P = 0.1057);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at